ArticleJournal of plant research2025
Isolation and functional identification of Jasmonte resistant 1, a Jasmonic acid isoleucine-conjugating enzyme in Catharanthus roseus.
Article in Journal of plant research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
Abstract
Jasmonate resistant 1 (JAR1), which encodes a jasmonate-amino synthase, mediates the biosynthesis of jasmonoyl-isoleucine (JA-Ile), the bioactive form of jasmonate involved in JA signal transduction pathway. Although JAR1 has been characterized in several plant species, its regulatory function in mediating JA signaling to modulate the biosynthesis of terpenoid indole alkaloids (TIAs) in Catharanthus roseus, a medicinal and ornamental plant, have not been previously investigated. In this study, we have identified and cloned CrJAR1, a member of the Gretchen Hagen3 (GH3) gene family, from C. roseus and confirmed its enzymatic activity in JA-Ile formation via heterologous expression in E. coli. Functional analyses using transient overexpression and virus-induced gene silencing (VIGS) in C. roseus leaves revealed that CrJAR1 positively regulates the accumulation of catharanthine and vindoline. Moreover, we demonstrated that CrCOI1, the jasmonate receptor, functions synergistically with CrJAR1 in modulating TIA biosynthesis. Co-silencing of CrCOI1 and CrJAR1 resulted in a lower sensitivity to exogenous JA treatment compared to silencing of CrJAR1 alone, indicating distinct yet complementary roles in jasmonate-mediated metabolic regulation. These results advance our understanding the function of CrJAR1 and offer new strategies for engineering specialized metabolite biosynthesis in plants.
Indexed as
Identifiers
40478496What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.